marijuana stocks news

Mentor Capital Securities Issued to Cannabis Investor

Medical Marijuana Related Incubator Program Benefits Investors and Founders

Mentor Capital, Inc. (MNTR) reports that it has sold $120,000 in securities convertible into a to-be-created series of preferred stock which itself will be convertible into shares of Mentor Capital common stock. The securities are structured to be related to preferred securities that are intended to be issued in connection with Mentor’s larger public company incubator program.

“We are excited and pleased to be working with Mentor Capital, Inc. Certainly, our relationship with Mentor will help our continued growth and diversification in this industry,” says Richard Wheeler, CEO of Canyon Crest Holdings, LLC.

“The Mentor Capital program is designed carefully to benefit all parties,” explains Mentor CEO, Chet Billingsley.

Rule 135(c) Disclosure Statement: The sales of these securities were made in reliance upon Rule 506 and Section 4(2) of the Securities Act of 1933, as amended (the “Act”) and such securities have not been registered and will not be registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This current report is neither an offer to sell, nor a solicitation of offers to purchase securities.

About Mentor Capital: The Company seeks to come alongside and assist medical marijuana and cannabis companies and to assist founders in meeting their objectives, to add protection for investors and to help incubate private cannabis companies. Additional important information for investors is presented at: www.MentorCapital.com.

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel and in protecting intellectual property. Further information concerning these and other risks is included in the Company’s 10-K and 10-Q filings including the Company’s most recent Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 which, along with other very important information about the Company, can be found filed with the SEC and here:

https://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.

Contact:
Mentor Capital, Inc.
Chet Billingsley, 760-788-4700
CEO

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Trulieve Cannabis Corp. (TCNNF) Reports Fourth Quarter and Full Year 2023 Results

Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End…

$VGPR Reschedules Open House at Virginia Plant

Vega Biofuels Reschedules Open House at Virginia Plant August Event to Showcase…

$PMCB Member Publishes Review Article on Use of Genetic Engineering to Treat Diabetes

PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article on Use of Genetic…

TILT Holdings Inc. (TLLTF) Reports Second Quarter 2024 Results

TILT Holdings Reports Second Quarter 2024 Results TILT Holdings Inc. (“TILT” or…